Fundz

Watching Tonix Pharmaceuticals Holding Corp.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNegative

Tonix Pharmaceuticals Holding Corp.

Filed: Jul 20, 2026CIK: 001-36019Health Care
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Dr. Gregory M. Sullivan, Chief Medical Officer of Tonix Pharmaceuticals, announced his retirement effective August 20, 2026. This executive departure may impact the company's pharmaceutical development strategy and investor confidence during a critical period.

Key Takeaways

Dr. Gregory M. Sullivan is retiring as Chief Medical Officer with an effective date of August 20, 2026

The company must identify and onboard a replacement CMO to maintain continuity in pharmaceutical product development

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJul 20, 2026
Item5.02
CategoryExecutive Change
CIK001-36019
Risk LevelMEDIUM
SentimentNegative
Signalrisk
Topics
executive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Tonix Pharmaceuticals Holding Corp. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.